SCHEMBL30412531

SCHEMBL30412531

CCNC(C)Cc1ccccc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.51
▸ SLC6A4 P31645 6/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ ADRA2C P18825 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ DRD3 P35462 1/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ HTR2B P41595 1/20 0.51
▸ IDO1 P14902 2/20 0.42
▸ PPARG P37231 5/20 0.40
▸ EPHX2 P34913 4/20 0.40
▸ SLC6A2 P23975 3/20 0.40
▸ POLB P06746 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10379774 1.00 SIGMAR1 (0.51) SIGMAR1SLC6A4LMNAMAPTADRA2C
SCHEMBL320896 0.78 IDO1 (0.50) SLC6A4IDO1PPARGEPHX2SLC6A2
SCHEMBL13003553 0.77 IDO1 (0.46) SLC6A4IDO1PPARGEPHX2SLC6A2
SCHEMBL10561344 0.77 SIGMAR1 (0.56) SIGMAR1SLC6A4LMNAMAPTADRA2C
SCHEMBL18893127 0.77 EPHX2 (0.44) IDO1PPARGEPHX2POLBMAPK1
Hydrochloric Acid SCHEMBL4680281 0.76 SIGMAR1 (0.55) SIGMAR1SLC6A4LMNAMAPTADRA2C
SCHEMBL30184157 0.75 IDO1 (0.47) SLC6A4IDO1PPARGEPHX2SLC6A2
SCHEMBL15160740 0.75 IDO1 (0.47) SLC6A4IDO1PPARGEPHX2SLC6A2
SCHEMBL4669556 0.75 IDO1 (0.52) SIGMAR1SLC6A4HTR2AHTR2BIDO1
SCHEMBL2426168 0.75 IDO1 (0.47) SLC6A4IDO1PPARGEPHX2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4293009-B1 FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME ZOGENIX INTERNATIONAL LTD (GB) 2025-06-11 — — EP disclosed
EP-3800177-B1 FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME ZOGENIX INTERNATIONAL LTD (GB) 2025-01-29 — — EP disclosed
EP-4293009-A2 FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME Zogenix International Limited (GB) 2023-12-20 — — EP disclosed
US-11634377-B2 Fenfluramine compositions and methods of preparing the same ZOGENIX INTERNATIONAL LIMITED (GB) 2023-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634377-B2 Fenfluramine compositions and methods of preparing the same FAAH, FAAH2, TPH1 SIGMAR1 1220/4885SLC6A4 203/4885LMNA 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback